Oral Versus Parental Progesterone in the Management of Preterm Labor
NCT ID: NCT03343795
Last Updated: 2018-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
80 participants
INTERVENTIONAL
2017-07-05
2018-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Preterm delivery has been, and remains, the most important challenge to modern obstetrics. In 2009, 13 million babies were born preterm, 11 million in Africa and Asia and 500,000 in the USA, The highest rates of preterm birth are in Africa (11.9%) and North America (10.6%)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Different Types of Progesterone in the Prevention of Preterm Labor
NCT03537287
Oral Progesterone for Prevention of Preterm Birth
NCT01180296
The Use of Progesterone to Reduce Preterm Birth
NCT00830765
Comparing IM vs. Vaginal Progesterone for Pre-term Birth
NCT00579553
Adjunctive Vaginal Progesterone in Management of Preterm Labor
NCT05997563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group 1
oral progesterone
oral progesterone
daily
study group 2
intramuscular progesterone
intramuscular progesterone
every week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral progesterone
daily
intramuscular progesterone
every week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Singleton pregnancy.
3. Pregnancy of less than 20 weeks of gestation
Exclusion Criteria
2. Underwent cervical cerclage in this pregnancy .
3. Multiple gestations .
4. Major fetal congenital malformations .
5. Pregnancy 0f more than 20 weeks gestation .
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Abbas
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut Faculty of Medicine
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PPTL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.